Dan I Lubman


BSc (Hons), MBChB, PhD, FRANZCP, FAChAM, Director, Turning Point, Vic; Professor of Addiction Studies and Services, Monash University, Vic

The assessment and management of gamma hydroxybutyrate use in general practice

Gamma hydroxybutyrate is associated with a disproportionate burden of harm despite low overall population prevalence of use.

The six Rs of managing high-risk opioid prescribing

Patients prescribed high doses of opioids need to be managed appropriately to reduce risks of morbidity and mortality.

Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine

Buprenorphine–naloxone is well tolerated by patients with chronic pain, and has the potential to improve pain scores and affective symptoms.